These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20398593)

  • 21. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Top HIV experts convene at national HIV prevention conference.
    AIDS Policy Law; 2003 Aug; 18(15):1, 4. PubMed ID: 14974378
    [No Abstract]   [Full Text] [Related]  

  • 24. [Viral hepatitis. Prevention, screening and research].
    de la Brière A
    Soins; 2013 Nov; (780):19. PubMed ID: 24409608
    [No Abstract]   [Full Text] [Related]  

  • 25. Potential consequences of healthcare recommendations: a focus on the U.S. Preventive Services Task Force.
    Satoskar R; Reau N
    Hepatology; 2013 Jul; 58(1):422-7. PubMed ID: 23460345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reports from today's health care environment on the implementation of screening, diagnosis, and treatment recommendations.
    Kim WR; Valdiserri RO; Wright LN; Manos MM; Do ST
    J Fam Pract; 2010 Apr; 59(4 Suppl):S43-50. PubMed ID: 20398590
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epidemiology of chronic hepatitis B and C among dialysis patients in Switzerland].
    Ambühl PM; Binswanger U; Renner EL
    Schweiz Med Wochenschr; 2000 Mar; 130(10):341-8. PubMed ID: 10763211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B and C viral infections in chronic liver disease: a population based study in Qatar.
    Rikabi A; Bener A; Al-Marri A; Al-Thani S
    East Mediterr Health J; 2009; 15(4):778-84. PubMed ID: 20187528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HBV and HCV coinfections in children--own investigations].
    Pawłowska M; Halota W
    Przegl Epidemiol; 2003; 57(3):459-64. PubMed ID: 14682164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.
    Kołtan S; Wysocki M; Kołtan A; Swiatkiewicz V; Styczyński J; Debski R; Balcar-Boroń A
    Med Sci Monit; 2002 Apr; 8(4):CR274-9. PubMed ID: 11951070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epidemiology and natural history of HIV/HBV and HIV/HCV co-infections.
    Mathews G; Bhagani S
    J HIV Ther; 2003 Nov; 8(4):77-84. PubMed ID: 14671504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The invisible IDU.
    Raymond D
    GMHC Treat Issues; 2005; 19(5-6):16. PubMed ID: 16193580
    [No Abstract]   [Full Text] [Related]  

  • 35. The Institute of Medicine report on viral hepatitis: a call to action.
    Sanyal AJ;
    Hepatology; 2010 Mar; 51(3):727-8. PubMed ID: 20198626
    [No Abstract]   [Full Text] [Related]  

  • 36. New HIV incidence estimates underscore the need for a national commitment to prevention.
    Carbaugh K
    J Assoc Nurses AIDS Care; 2008; 19(6):419-22. PubMed ID: 19007719
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses.
    Inchauspé G; Michel ML
    J Viral Hepat; 2007 Nov; 14 Suppl 1():97-103. PubMed ID: 17958650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis C and B (HCV, HBV)].
    Violante MD
    Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():101-3. PubMed ID: 17037789
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV prevention efforts reach a crossroads as signs point to rising infections. Meanwhile, politics is deciding prevention strategy.
    AIDS Alert; 2003 Jun; 18(6):69, 71-3. PubMed ID: 12866473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical examinations based on nucleic acids of hepatitis viruses].
    Tanaka Y; Mizokami M
    Rinsho Byori; 2006 Nov; 54(11):1164-71. PubMed ID: 17240839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.